Suppr超能文献

利尿剂、β受体阻滞剂或两者联合用于原发性高血压的治疗。

Diuretics, beta-blockers or both as treatment for essential hypertension.

作者信息

Stumpe K O, Overlack O

出版信息

Br J Clin Pharmacol. 1979;7 Suppl 2(Suppl 2):189S-197S. doi: 10.1111/j.1365-2125.1979.tb04690.x.

Abstract

1 Patients with borderline (group I) and sustained hypertension (group II) were treated with beta-blocking drugs, diuretics and the combination of both. In the two groups of patients the antihypertensive effectiveness of both short-term intravenous or chronically oral propranolol was directly related to the extent to which the drug produced an absolute reduction in plasma renin activity (PRA). No such a correlation could be obtained with pindolol. In group I following beta-blockade, day-night profiles of PRA were similar to those observed in group II before treatment. Thus, in this latter subgroup, low renin profiles might reflect reduced beta-adrenergic activity. 2 When the chronically beta-blockaded patients were changed to chronic diuretic therapy it became evident that young hypertensive patients of group II showed a more pronounced BP response than the patients of group I. In those patients of group II in whom pressure was not controlled by the diuretic alone, combination with a beta-blocker led to pressure normalization. 3 The beta-blocking drug induced reduction in pressure was greater in the 25-35 yr olds, than in those older than 55. In contrast, the antihypertensive effect of the diuretic was more pronounced in the 55-70 yr olds than in those younger than 40. 4 It is concluded that sympathetic nervous system activity mainly determined PRA as well as antihypertensive effectiveness of both the beta-blockers and the diuretics. As to outpatient management it is proposed that with exception of young borderline hypertensives who seem to respond best to beta-blockers, initial antihypertensive drug therapy may consist of a diuretic agent. If the antihypertensive effect of the diuretic is insufficient, combination with a beta-blocking drug could be used to achieve the best effect.

摘要
  1. 临界高血压患者(I组)和持续性高血压患者(II组)接受了β受体阻滞剂、利尿剂以及二者联合治疗。在这两组患者中,短期静脉注射或长期口服普萘洛尔的降压效果与药物使血浆肾素活性(PRA)绝对降低的程度直接相关。而吲哚洛尔未显示出这种相关性。在I组中,β受体阻滞剂治疗后,PRA的昼夜变化模式与II组治疗前观察到的相似。因此,在后者这一亚组中,低肾素模式可能反映了β肾上腺素能活性降低。2. 当长期接受β受体阻滞剂治疗的患者改为长期利尿剂治疗时,很明显II组的年轻高血压患者比I组患者表现出更明显的血压反应。在II组中那些仅用利尿剂不能控制血压的患者中,加用β受体阻滞剂可使血压恢复正常。3. β受体阻滞剂引起的血压降低在25 - 35岁人群中比在55岁以上人群中更明显。相反,利尿剂的降压作用在55 - 70岁人群中比在40岁以下人群中更显著。4. 得出的结论是,交感神经系统活性主要决定了PRA以及β受体阻滞剂和利尿剂的降压效果。关于门诊治疗,建议除了似乎对β受体阻滞剂反应最佳的年轻临界高血压患者外,初始降压药物治疗可采用利尿剂。如果利尿剂的降压效果不足,可加用β受体阻滞剂以达到最佳效果。

相似文献

4
Angiotensin II blockade during combined thiazide-beta-adrenoreceptor-blocker treatment.
Clin Sci (Lond). 1979 Dec;57 Suppl 5:123s-125s. doi: 10.1042/cs057123s.
7
Veterans Administration cooperative study on nadolol as monotherapy and in combination with a diuretic.
Am Heart J. 1984 Oct;108(4 Pt 2):1087-91. doi: 10.1016/0002-8703(84)90586-6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验